FDA Clearance Tracker · P920014-S029
THORATEC HEARTMATE XVE LVAS
Last checked: Nov 20, 2026Latest source record: Mar 13, 2009 (this decision)Source: openFDAMethods & limitations
Decided
Mar 13, 2009
Approved
Time to decision
239 days
Received Jul 17, 2008. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P920014-S029
- Device name
- THORATEC HEARTMATE XVE LVAS
- Applicant
- Thoratec Corp
- Applicant location
- Pleasanton, CA
- Received
- Jul 17, 2008
- Decided
- Mar 13, 2009
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P920014
Device type
- Device type
- Ventricular (assist) bypass (DSQ)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR MODIFICATIONS TO THE EXTERNAL PERIPHERALS.
Source documents
Other decisions for Thoratec Corp
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.